Vimarsana
Biggest News Aggregation in the World

Page 3 - Script Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Script Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Script Biotech Today - Breaking & Trending Today

GenScript Named a BioSpace 2024 Best Place to Work - Vimarsana News

GenScript Named a BioSpace 2024 Best Place to Work

BioSpace's Best Places to Work report celebrates the top 30 small and large biopharma employers across America, and demonstrates a company's desirability in the recruitment marketplace, based on the...

GenScript Biotech and T-MAXIMUM Biotech Form Strategic Alliance on cGMP sgRNA - Vimarsana News

GenScript Biotech and T-MAXIMUM Biotech Form Strategic Alliance on cGMP sgRNA

/PRNewswire/ -- GenScript Biotech, the world's leading life-science research tools and services provider, and T-MAXIMUM Biotech, a biotechnology company...

GenScript Expands Peptide Production Capabilities to Include Neoantigen Peptides and APIs - Vimarsana News

GenScript Expands Peptide Production Capabilities to Include Neoantigen Peptides and APIs

/PRNewswire/ -- GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, has ramped up production of complex...

GenScript to Host Third Annual Gene & Cell Engineering Virtual Summit - Vimarsana News

GenScript to Host Third Annual Gene & Cell Engineering Virtual Summit

/PRNewswire/ -- GenScript USA Inc., the world's leading life-science research tools and services provider, announced its third annual GenScript Gene & Cell...

GenScript to Host Third Annual Gene & Cell Engineering Virtual Summit - Vimarsana News

GenScript to Host Third Annual Gene & Cell Engineering Virtual Summit

Free, one-day online event features life-science leaders from academia, pharma, and biotech who are leveraging the strengths of synthetic biology technologies to develop life-changing...